Elevance Health Inc. (ELV) Tops Q1 EPS by 16c, tops guidance

Elevance Health Inc. (NYSE: ELV) reported Q1 EPS of $10.64, $0.16 better than the analyst estimate of $10.48. Revenue for the quarter came in at $42.3 billion versus the consensus estimate of $42.47 billion.

GUIDANCE:

Elevance Health Inc. sees FY2024 EPS at greater of $37.20, versus the consensus of $37.15.

For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• KeyBanc Upgrades Nucor (NUE) to Overweight
• Cerebras Q1 EPS miss sends shares down 9% after-hours